kdr2-2
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 26, 2020 (NCT04620109)
Timeline
Indications
Mechanism of action
KDR antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05011916 | Phase 1/Phase 2 (Phase 2) | Aug 10, 2021 | Sun Yat-Sen University |
| NCT04844619 | Phase 2 | Apr 19, 2021 | Sun Yat-Sen University |
| NCT04620109 | Phase 1 | Aug 26, 2020 | Government of China, Parexel |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sun Yat-Sen University | Academic/Hospital | 2 | 2 | 1 | 2021 |
| Government of China | Government | 1 | 1 | 1 | 2020 |
| Parexel | For profit | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1